Picture of AptaBio Therapeutics logo

293780 AptaBio Therapeutics Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for AptaBio Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments19,69446,15842,82522,91116,995
Net Total Accounts Receivable
Net Total Receivables1663236804793,047
Prepaid Expenses
Total Other Current Assets
Total Current Assets19,94646,76743,74523,77720,419
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment2874,0334,8894,8225,848
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets20,32877,40475,44464,91156,114
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1,1767318017881,040
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities2,0172,2493,4033,2463,744
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity18,31275,15572,04061,66552,370
Total Liabilities & Shareholders' Equity20,32877,40475,44464,91156,114
Total Common Shares Outstanding